Anesthesia Medical News about Myotonia Myotonia Congenita

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. Doctors and the DEA Free full text

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

The Myotonias and Susceptibility to Malignant Hyperthermia
Anesthesia & Analgesia, 09/18/09

Parness J et al. – Malignant hyperthermia (MH) is a pharmacogenetic disorder of skeletal muscle in which volatile anesthetics trigger a sustained increase in intramyoplasmic Ca2+ via release from sarcoplasmic reticulum and, possibly, entry from the extracellular milieu that leads to hypermetabolism, muscle rigidity, rhabdomyolysis, and death.

<< Previous
In Vitro Inhibition of Factor XIII Retards Clot Formation,...

Next >>
Defining the role of recombinant activated factor VII in...

Acquired monosomy 7 myelodysplastic syndrome in a child with clinical features suggestive of dyskeratosis congenita and IMAGe association
Pediatric Blood & Cancer, 10/07/09 Relevance Score: 42%

Irregular purplish blue markings on the limbs of a newborn
The Clinical Advisor, 11/11/09 Relevance Score: 41%

Rapamycin selectively inhibits expression of an inducible keratin (K6a) in human keratinocytes and improves symptoms in pachyonychia congenita patients
Journal of Dermatological Science, 10/06/09 Relevance Score: 41%